New Zealand markets open in 7 hours 40 minutes

Pfizer Inc. (PFE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
52.54+1.00 (+1.94%)
At close: 04:03PM EST
53.01 +0.47 (+0.89%)
Pre-market: 08:20AM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 303.38B
Enterprise value 312.09B
Trailing P/E 15.71
Forward P/E 9.46
PEG ratio (5-yr expected) 1.28
Price/sales (ttm)4.43
Price/book (mrq)4.01
Enterprise value/revenue 4.50
Enterprise value/EBITDA 11.30

Trading information

Stock price history

Beta (5Y monthly) 0.64
52-week change 344.98%
S&P500 52-week change 316.15%
52-week high 361.71
52-week low 333.36
50-day moving average 354.67
200-day moving average 345.39

Share statistics

Avg vol (3-month) 344.82M
Avg vol (10-day) 335.84M
Shares outstanding 55.61B
Implied shares outstanding 6N/A
Float 85.61B
% held by insiders 10.04%
% held by institutions 167.56%
Shares short (30 Dec 2021) 458.64M
Short ratio (30 Dec 2021) 41.19
Short % of float (30 Dec 2021) 41.04%
Short % of shares outstanding (30 Dec 2021) 41.04%
Shares short (prior month 29 Nov 2021) 463.56M

Dividends & splits

Forward annual dividend rate 41.6
Forward annual dividend yield 43.05%
Trailing annual dividend rate 31.55
Trailing annual dividend yield 33.01%
5-year average dividend yield 43.67
Payout ratio 445.06%
Dividend date 303 Mar 2022
Ex-dividend date 426 Jan 2022
Last split factor 21054:1000
Last split date 316 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)02 Oct 2021

Profitability

Profit margin 28.68%
Operating margin (ttm)32.14%

Management effectiveness

Return on assets (ttm)7.78%
Return on equity (ttm)27.75%

Income statement

Revenue (ttm)69.34B
Revenue per share (ttm)12.41
Quarterly revenue growth (yoy)134.40%
Gross profit (ttm)33.33B
EBITDA 27.31B
Net income avi to common (ttm)19.57B
Diluted EPS (ttm)3.50
Quarterly earnings growth (yoy)454.50%

Balance sheet

Total cash (mrq)29.7B
Total cash per share (mrq)5.29
Total debt (mrq)39.88B
Total debt/equity (mrq)52.50
Current ratio (mrq)1.38
Book value per share (mrq)13.49

Cash flow statement

Operating cash flow (ttm)32.29B
Levered free cash flow (ttm)42.43B